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Abstract
Background:  The presence of a hypervascular nodule in a patient with cirrhosis is highly
suggestive of a hepatocellular carcinoma.
Case presentation: A 55 year old man with idiopathic refractory anaemia was addressed for the
cure of a recently appeared 3.3 cm hypervascular liver nodule. The nodule was not visible on the
resected fresh specimen, but a paler zone was seen after formalin fixation. The surrounding liver
was fibrotic (METAVIR score F3) and overloaded with iron. However, the paler zone, thought to
be the nodule, had in fact a normal architecture, was less fibrotic, and contained some "portal tract-
like structures" (but with arteries only); moreover, this paler area was devoid of iron, contained
less glycogen and was characterized by foci of clear hepatocytes.
Conclusion: In spite of the absence of architectural distortion, and a normal proliferative index,
the possibility of premalignancy or malignancy should be considered in this type of hypervascular
and hyposiderotic nodule, occurring in the context of an iron overloaded liver.
Background
The presence of a hypervascular nodule in a patient with
liver disease is highly suggestive of a hepatocellar carci-
noma (HCC) [1]. Increased iron stores in patients with
HCC developed on a non-cirrhotic liver is well docu-
mented [2-5]; iron stores are seldom depleted at the time
of the discovery of the HCC [6]. Few cases of premalignant
nodules associated with HCC have also been reported
under these circumstances [7,8]. In a fibrotic liver over-
loaded with iron, we report a case of a hypervascular and
hyposiderotic nodule with premalignant features, but
with a normal architecture.
Case presentation
General data
A 55 year old man with idiopathic refractory anaemia was
addressed to our Unit for the cure of a recently appeared
3.3 cm hypervascular liver nodule in segment II (Novem-
ber, 2003). Physical examination was normal, including
BMI. Liver function tests were as follows: ASAT = 53 IU/L
(Normal = 40); ALAT = 58 IU/L (N = 50); Billirubin = 44
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µmol/L (N = 17); PT = 70% (N = 70–100); V = 65% (N =
70–100); RBC = 2.9 × 106 cells/µl; Ht = 22.5% and Hb =
7.3 gm/dl; WBC = 4.6 × 103 cells/µl; and platelets = 210 ×
109 /l. Ferritinemia was 1891 ng/l (N < 300), transferrin
saturation was 100% (N < 40), iron concentration was
290 µmol/g (assessed by MRI, N < 36). AFP in blood was
within the normal range. The patient, of Italian origin,
was C282 Y -/-, H63D +/-, and S65C -/-, with no family
history of iron overload. Markers for viral and autoim-
mune diseases were negative. Blood glucose was normal.
He used to smoke 30 cigarettes per day; but had stopped
for the last 8 years. He drank alcohol only occasionally.
The treatment of his refractory anaemia consisted in
blood transfusion (total of 10 packs), Desferoxamine, and
Deferiprone.
Imaging results
Ultrasound examination showed a hypoechogenic ovoid
nodule (3.2 × 1.9 cm) in segment II. MRI showed a
hypointense non-tumoral liver on T1- and T2-weighted
images due to iron overload. In comparison, the nodule
was hyperintense on T1- and T2-weighted images. After
gadolinium injection, the nodule was hyperintense on T1-
weigthed images and remained so in the portal phase (Fig.
Hyperintensity of the nodule on T1- and T2-weighted images (left), which remains so after gadolinium injection (right), on T1- weigthed image in the portal phase Figure 1
Hyperintensity of the nodule on T1- and T2-weighted images (left), which remains so after gadolinium injection (right), on T1-
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1).
Liver pathology
On December 2003, a left lobe hepatectomy was per-
formed laparoscopically. Follow-up was uneventful. The
resected specimen was carefully sliced but no nodule was
found on the fresh specimen, and in the expected area.
However, after formalin fixation, a 2 cm in diameter paler
area was identified (Fig. 2, arrow). All slices were routinely
processed. The following stainings were performed: H&E,
trichrome, Perls, reticulin, PAS, and several immunostains
(CD34, cytokeratins 7 and 19, CRBP1 and α -SMA; the lat-
ter for identification of quiescent and/or activated hepatic
stellate cells [9]). The liver was fibrotic (METAVIR score
F3) (Figs. 3a, 4a) with an iron overload 3 + (according to
Searle score), mainly in hepatocytes of zones 1 and 2 (Fig.
5a). Liver iron concentration was 286 µmol/g (n < 36),
and the iron concentration / age ratio was 5.1. Small foci
of clear cells devoid of iron were also observed (not
shown).
The paler zone, poorly limited from the adjacent paren-
chyma, was strikingly different. The architecture was pre-
served but the area was far less fibrotic (METAVIR score
F1; Figs. 3b, 4b), with less iron (Fig. 5b), less glycogen
(Fig. 6a), and with foci of clear hepatocytes (Figs. 6a, 6b).
In these clear areas, hepatocytes were slightly bigger and
occasionally displayed in two cell-thick plates. In these
areas, as elsewhere, reticulin network, as well as Ki-67
(Mib-1) and CD34 were normal (not shown). One of the
Formalin fixed specimen: a flat and slightly clearer area is visible in the expected zone (arrow) Figure 2
Formalin fixed specimen: a flat and slightly clearer area is visible in the expected zone (arrow).
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Septal fibrosis in non tumoral liver (a), contrasting with absence of fibrosis in the nodule (b) Figure 3
Septal fibrosis in non tumoral liver (a), contrasting with absence of fibrosis in the nodule (b). Masson's trichrome.
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Septal fibrosis in non tumoral liver (a), contrasting with absence of fibrosis in the nodule (b) Figure 4
Septal fibrosis in non tumoral liver (a), contrasting with absence of fibrosis in the nodule (b). Reticulin staining.
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Iron overload in non tumoral liver (a), contrasting with less iron in the nodule (b) Perls staining Figure 5
Iron overload in non tumoral liver (a), contrasting with less iron in the nodule (b) Perls staining.
5a
5bComparative Hepatology 2005, 4:5 http://www.comparative-hepatology.com/content/4/1/5
Page 7 of 11
(page number not for citation purposes)
PAS staining: (a) foci of clear hepatocytes (arrow) close to the border between the non tumoral PAS positive zone, on the left  side, and the PAS negative nodule on the right side of the photograph; (b) a clear focus in the nodule Figure 6
PAS staining: (a) foci of clear hepatocytes (arrow) close to the border between the non tumoral PAS positive zone, on the left 
side, and the PAS negative nodule on the right side of the photograph; (b) a clear focus in the nodule.
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most striking findings was the presence of different types
of portal tracts: some were normal (Fig. 7), whereas others
contained mainly ductules (Fig. 8) and others arteries
(Fig. 9). Regarding the number of CRBP1 and α -SMA pos-
itive cells, no obvious differences were seen between the
fibrotic and non-fibrotic parts of the liver. CRBP 1 positive
cells seemed to contain few lipid droplets.
Discussion
The mechanism accounting for the major hepatic iron
overload is possibly multifactorial, including refractory
sideroblastic anemia and blood transfusion, although the
patient received only a limited number (<10) of blood
transfusions. An associated hereditary iron overload such
as transferrin receptor 2 haemochromatosis in this Italian
patient cannot be ruled out.
Premalignant lesions have previously been described in
iron overloaded patients in the absence of cirrhosis,
although these lesions were discovered in the clinical con-
text of a HCC [7,8]. To our knowledge, this is the first
reported case of a premalignant area mimicking by imag-
ing a HCC, but exhibiting microscopically a still well-pre-
served architecture, in an otherwise fibrotic liver.
The hyperarterialized nodule did not correspond to a
macroscopically visible nodule, but rather to an ill-
defined area with preserved architectural organization.
Normal portal tract in the nodule Figure 7
Normal portal tract in the nodule. H&E staining.
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However, this area was considered as premalignant based
on the following arguments: arterial hypervascularization
with isolated arteries in the parenchyma [3]; loss of iron
[10], and of glycogen; and presence of clear hepatocytes
foci [11]. The diagnosis of a focal nodular hyperplasia
(FNH)-like nodule as described in cirrhosis [12-14], par-
ticularly related to alcohol, seems unlikely due to the loss
of iron and to the presence of clear hepatocytes foci.
Nonetheless, that diagnosis cannot be ruled out, and
should always be kept in mind, especially if a liver
transplantation is foreseen. Recently, it has been reported
that coexisting iron overload could significantly worsen
the course of FNH [15]. Unfortunately, and because no
frozen material of the lesion (which was not visible) was
available, in this case no specific molecular studies could
be carried out to settle that important issue.
Our case strengthens previous observations [7,8] showing
that malignancy can overrun cirrhosis in iron overload
(Fig. 10). A minor degree (stage) of fibrosis in areas
devoid of iron could be a direct consequence of iron loss
(less toxicity) and/or related to the malignant process
[16,17] in its early phase (as denoted by absence of cellu-
lar disorganization, and negativity of the MIB-1 immu-
nostaining). It was concluded that this patient needs a
strict surveillance because he may be at risk of recurrence.
Indeed, clear hepatocytes foci devoid of iron were also
observed outside the nodule [10].
On the left side, ductular reaction around a portal tract in the nodule Figure 8
On the left side, ductular reaction around a portal tract in the nodule. On the right side, in another portal tract the bile duct is 
visible but not the portal vein and the artery. CK7 immunostaining.
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Conclusion
The possibility of premalignancy or malignancy should be
considered even in the absence of cirrhosis, when a nod-
ule is observed in a patient with past or present liver iron
overload.
List of abbreviations used
AFP – α -fetoprotein; ALAT – alanine aminotransferase;
ASAT – aspartate aminotransferase; BMI – body-mass
index; CRBP1 – cellular retinol-binding protein 1; FNH –
focal nodular hyperplasia; Hb – hemoglobin; Ht – hema-
tocrit; HCC – hepatocellar carcinoma; MRI – magnetic
resonance imaging; PAS – periodic acid Schiff; PT – pro-
trombine time; RBC – red blood cells; α -SMA – α -smooth
muscle actin; WBC – white blood cells.
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An unpaired artery in the nodule Figure 9
An unpaired artery in the nodule. α -SMA immunostaining.
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Pathways leading to HCC in iron overload: (a) classical pathway; (b) alternate pathway (rarely observed) Figure 10
Pathways leading to HCC in iron overload: (a) classical pathway; (b) alternate pathway (rarely observed).
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